Outcomes in #Children and #Adults With #Antiglomerular #Basement Membrane Disease #AntiGBM

#VisualAbstract by Corina Teodosiu

www.kireports.org/article/S2468-0249(26)02...

FDA Grants Orphan Drug Designation to Veverimer for Anti-GBM Disease | Docwire News The FDA granted Orphan Drug Designation to veverimer for anti–glomerular basement membrane (anti-GBM) disease, a rare autoimmune condition that causes acute renal failure.

ICYMI: The FDA granted ODD to veverimer to treat anti–glomerular basement membrane disease. #raredisease #autoimmune #antigbm #nephrology #nephsky
www.docwirenews.com/post/fda-gra...

Efficacy and Safety of #Rituximab in Antiglomerular Basement Membrane Disease #AntiGBM

#VisualAbstract by @Arjun_Mohan1

www.kireports.org/ar...

All fellowship programs should participate #GlomCon @GlomCon1. What an amazing session yesterday via trivia on #antigbm